| ACovPid | Against Virus | Inhibition Value Type | Inhibitory Effect | Inhibitory Unit | Target Domain Name | Detail |
|---|---|---|---|---|---|---|
| ACoVP100141 | Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1) : 1263720 | IC50 | 0.5 | µM | HR1 domain of SARS-CoV-2 | more |
| ACoVP100142 | Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1) : 1263720 | IC50 | HR1 domain of SARS-CoV-2 | more | ||
| ACoVP100143 | Severe acute respiratory syndrome coronavirus (SARS-CoV) : 694009 | IC50 | 0.0043±0.00218 | µM | more | |
| ACoVP100144 | Severe acute respiratory syndrome coronavirus (SARS-CoV) : 694009 | IC50 | 0.00699±0.00071 | µM | more | |
| ACoVP100145 | Severe acute respiratory syndrome coronavirus (SARS-CoV) : 694009 | IC50 | 0.00188±0.00052 | µM | more | |
| ACoVP100146 | Severe acute respiratory syndrome coronavirus (SARS-CoV) : 694009 | IC50 | 0.00621±0.00213 | µM | more | |
| ACoVP100147 | Severe acute respiratory syndrome coronavirus (SARS-CoV) : 694009 | IC50 | 0.00547±0.00041 | µM | more | |
| ACoVP100148 | Severe acute respiratory syndrome coronavirus (SARS-CoV) : 694009 | IC50 | 0.00207±0.00101 | µM | more | |
| ACoVP100149 | Severe acute respiratory syndrome coronavirus (SARS-CoV) : 694009 | IC50 | 50 | µM | RBD of SARS-CoV | more |
| ACoVP100150 | Severe acute respiratory syndrome coronavirus (SARS-CoV) : 694009 | IC50 | 6 | µM | RBD of SARS-CoV | more |
| ACoVP100151 | Severe acute respiratory syndrome coronavirus (SARS-CoV) : 694009 | IC50 | 0.1, | µM | RBD of SARS-CoV | more |
| ACoVP100152 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | EC50 | 0.72 | µM | more | |
| ACoVP100153 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | EC50 | 0.32 | µM | more | |
| ACoVP100154 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | EC50 | 0.58 | µM | more | |
| ACoVP100155 | Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1) : 1263720 | IC50 | 0.574 | µM | RBD of MERS-CoV (Betacoronavirus England 1) | more |
| ACoVP100156 | Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1) : 1263720 | IC50 | 0.069 | µM | RBD of MERS-CoV (Betacoronavirus England 1) | more |
| ACoVP100157 | Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1) : 1263720 | IC50 | 0.511 | µM | RBD of MERS-CoV (Betacoronavirus England 1) | more |
| ACoVP100158 | Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1) : 1263720 | IC50 | 0.11 | µM | RBD of MERS-CoV (Betacoronavirus England 1) | more |
| ACoVP100159 | Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) (MERS-CoV) (MERS-CoV wild-type) | IC50 | 0.553±0.056 | µM | RBD of MERS-CoV (Betacoronavirus England 1) | more |
| ACoVP100160 | Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) (MERS-CoV) (MERS-CoV mutants isolated - D509G) | IC50 | 0.619±0.079 | µM | RBD of MERS-CoV (Betacoronavirus England 1) | more |